[Peroxisomal disorders: classification and overview of biochemical abnormalities]. 1999

H W Moser
Kennedy Krieger Institute, Baltimore, MD, USA.

The peroxisomal disorders are subdivided into two major categories: those in which the organelle is not formed normally (disorders of peroxisome biogenesis), and those that are associated with defects of single peroxisomal proteins. The Zellweger cerebrohepatorenal syndrome is the prototype of the peroxisome biogenesis disorders. It has been shown to be due to defective import of proteins into the organelle. Ten distinct molecular defects can lead to the failure of import.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297 Male Males
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001678 Organelle Biogenesis The natural growth and development within living CELLS. Mitochondrial Biogenesis,Biogeneses, Organelle,Biogenesis, Mitochondrial,Biogenesis, Organelle,Organelle Biogeneses
D018901 Peroxisomal Disorders A heterogeneous group of inherited metabolic disorders marked by absent or dysfunctional PEROXISOMES. Peroxisomal enzymatic abnormalities may be single or multiple. Biosynthetic peroxisomal pathways are compromised, including the ability to synthesize ether lipids and to oxidize long-chain fatty acid precursors. Diseases in this category include ZELLWEGER SYNDROME; INFANTILE REFSUM DISEASE; rhizomelic chondrodysplasia (CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC); hyperpipecolic acidemia; neonatal adrenoleukodystrophy; and ADRENOLEUKODYSTROPHY (X-linked). Neurologic dysfunction is a prominent feature of most peroxisomal disorders. Adrenoleukodystrophy, Neonatal,Hyperpipecolic Acidemia,Adrenoleukodystrophy, Autosomal Neonatal Form,Adrenoleukodystrophy, Autosomal, Neonatal Form,Hyperpipecolatemia,Neonatal Adrenoleukodystrophy,Peroxisomal Dysfunction, General,Peroxisomal Dysfunction, Multiple,Peroxisomal Dysfunction, Single,Acidemia, Hyperpipecolic,Acidemias, Hyperpipecolic,Adrenoleukodystrophies, Neonatal,Dysfunction, General Peroxisomal,Dysfunction, Multiple Peroxisomal,Dysfunction, Single Peroxisomal,Dysfunctions, General Peroxisomal,Dysfunctions, Multiple Peroxisomal,Dysfunctions, Single Peroxisomal,General Peroxisomal Dysfunction,General Peroxisomal Dysfunctions,Hyperpipecolic Acidemias,Multiple Peroxisomal Dysfunction,Multiple Peroxisomal Dysfunctions,Neonatal Adrenoleukodystrophies,Peroxisomal Disorder,Peroxisomal Dysfunctions, General,Peroxisomal Dysfunctions, Multiple,Peroxisomal Dysfunctions, Single,Single Peroxisomal Dysfunction,Single Peroxisomal Dysfunctions

Related Publications

H W Moser
February 1994, Genetika,
H W Moser
April 2005, Molecular genetics and metabolism,
H W Moser
June 1993, American journal of diseases of children (1960),
H W Moser
November 1988, No to hattatsu = Brain and development,
H W Moser
December 1988, American journal of diseases of children (1960),
H W Moser
June 1990, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
H W Moser
January 1994, European journal of pediatrics,
Copied contents to your clipboard!